TriSalus Life Sciences (TLSI) Other financing activities (2022 - 2026)

TriSalus Life Sciences' Other financing activities history runs 5 years deep, the most recent figure standing at $32000.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 88.53% year-over-year to $32000.0 in Q1 2026; TTM through Mar 2026 was $157000.0, a 54.89% decrease from a year earlier, with the FY2025 full-year figure at $404000.0, up 431.58% from the prior year.
• Other financing activities rose to $32000.0 in Q1 2026 per TLSI's latest filing, from -$19000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $9.5 million in Q2 2023 and bottomed at -$9.5 million in Q4 2023.
• The 5-year median for Other financing activities is $31000.0 (2023), against an average of $50857.1.
• Across the five-year window, Other financing activities slumped 45104.76% in 2023 and surged 4300.0% in 2025, its largest moves.
• Year by year, Other financing activities stood at $21000.0 in 2022, then slumped by 45104.76% to -$9.5 million in 2023, then soared by 100.66% to $62000.0 in 2024, then slumped by 130.65% to -$19000.0 in 2025, then soared by 268.42% to $32000.0 in 2026.
• Per Business Quant, the three latest TLSI Other financing activities figures stand at $32000.0 (Q1 2026), -$19000.0 (Q4 2025), and $88000.0 (Q3 2025).